Azenosertib

DB18028InvestigationalSmall molecule

Azenosertib: Overview.

Mechanism: Pharmacologically active on Wee1-like protein kinase
Curator reviewed
Formula / weight: C₂₉H₃₄N₈O₂ · 526.645 g/mol (avg)
Also known as: 3h-pyrazolo(3,4-d)pyrimidin-3-one, 1-((7r)-7-ethyl-6,7-dihydro-7-hydroxy-5h-cyclopenta(b)pyridin-2-yl)-1,2-dihydro-6-((4-(4-methyl-1-piperazinyl)phenyl)amino)-2-(2-propen-1-yl)-
Code names: KP-2638 · ZN-C3

Resolves to

Compound

Structure

InChIKeyOXTSYWDBUVRXFF-GDLZYMKVSA-NSMILESCC[C@@]1(O)CCC2=CC=C(N=C12)N1N(CC=C)C(=O)C2=CN=C(NC3=CC=C(C=C3)N3CCN(C)CC3)N=C12

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

18Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Azenosertib, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.